SKYAW

NASD SkyAI, Inc. - Warrant
Oct 21, 2026 · 6:07 PM ET LAST TRADE Market Closed

$0.0415 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.0415, $0.0141 below the day’s high of $0.0556

YTD change
-9.78%
vs 20-day SMA
-6.04%
vs 200-day SMA
N/A

Price ranges

Previous day
$0.0503 $0.0563
open $0.0563 close $0.0559
-$0.0004 (-0.71%)
Today
$0.0405 $0.0556
open $0.0452 now $0.0415
-$0.0037 (-8.19%)
Past week
$0.0503 $0.0746
from $0.0611 now $0.0415
-$0.0196 (-32.08%)
Past month
$0.0201 $0.2990
from $0.0316 now $0.0415
+$0.0099 (+31.33%)
This year
$0.0150 $0.2990
from $0.0460 now $0.0415
-$0.0045 (-9.78%)

Price & Performance

+0.01 (+21.52%) / 6M

$0.0148$0.0369$0.0590$0.0811May 28Aug 5Oct 20

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Poor
  • The stock is 86.1% away from all-time highs of $0.2990
  • SKYAW is down 10% since the beginning of the year
  • SKYAW is down 10% over the past 12 months
  • SKYAW is up 31% over the past 1 month

SKYAW reads poor: the 12-month move is +21.5%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable N/A
EPS N/A
Earnings momentum N/A Quarterly EPS growth
Quarterly change N/A

Valuation

P/E ratio N/A

Balance sheet & scale

IncomeN/A
RevenueN/A
CashN/A
DebtN/A
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Manufacturing
Sub Sector Miscellaneous Manufacturing
Market cap N/A

Competitor comparison

TickerCompany PriceChange
JNJ.CAT JOHNSON & JOHNSON CDR CAD HEDGED $33.05 +2.13%
BDX Becton, Dickinson and Company $193.80 +1.60%
DXCM DexCom, Inc. $85.74 -0.28%
MDLN Medline, Inc. Class A $35.46 +0.77%
WST West Pharmaceutical Services, Inc. $388.78 +1.27%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.